Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 3
2005 3
2006 3
2007 3
2008 3
2009 5
2010 9
2011 5
2012 6
2013 1
2014 2
2016 1
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group. Saito T, et al. Among authors: ueda s. Clin Exp Nephrol. 2017 Dec;21(6):961-970. doi: 10.1007/s10157-016-1340-2. Epub 2016 Oct 25. Clin Exp Nephrol. 2017. PMID: 27783276 Free PMC article. Clinical Trial.
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Shuto H, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group. Saito T, et al. Among authors: ueda s. Clin Exp Nephrol. 2014 Oct;18(5):784-94. doi: 10.1007/s10157-013-0925-2. Epub 2013 Dec 23. Clin Exp Nephrol. 2014. PMID: 24363128 Free PMC article. Clinical Trial.
[Diagnosis of drug induced nephropathy].
Ueda S. Ueda S. Nihon Jinzo Gakkai Shi. 2012;54(7):950-7. Nihon Jinzo Gakkai Shi. 2012. PMID: 23234204 Japanese. No abstract available.
[Rhabdomyolysis].
Ueda S. Ueda S. Nihon Rinsho. 2012 Aug;70 Suppl 6:676-80. Nihon Rinsho. 2012. PMID: 23156596 Japanese. No abstract available.
[Diagnosis on adverse drug reactions].
Ueda S. Ueda S. Nihon Rinsho. 2012 Aug;70 Suppl 6:25-8. Nihon Rinsho. 2012. PMID: 23156482 Japanese. No abstract available.
An angiotensin II type 1 receptor blocker prevents renal injury via inhibition of the Notch pathway in Ins2 Akita diabetic mice.
Koshizaka M, Takemoto M, Sato S, Tokuyama H, Fujimoto M, Okabe E, Ishibashi R, Ishikawa T, Tsurutani Y, Onishi S, Mezawa M, He P, Honjo S, Ueda S, Saito Y, Yokote K. Koshizaka M, et al. Among authors: ueda s. Exp Diabetes Res. 2012;2012:159874. doi: 10.1155/2012/159874. Epub 2012 Jan 29. Exp Diabetes Res. 2012. PMID: 22319521 Free PMC article.
47 results